Establishment of KRAS G12C Mutant Patient-Derived Xenograft (PDX) Models for Pre-Clinical Evaluation of KRAS G12C Targeted Anticancer Therapy.Wenting Shi,Xuzhen Tang,Jingying Zhang, Xinhong Kuang, Yan Zhang,Jingjing Wang,Qingyang Gu,Qunsheng JiCANCER RESEARCH(2021)引用 0|浏览20AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要